Hold XOM with dual-trigger conditional framework; structural floor intact prevents underweight, but near-term catalysts insufficient for overweight
Hold XOM with a disciplined conditional framework that preserves structural floor exposure without chasing resistance. The neutral analyst's dual-trigger synthesis materially improves the trader's open-ended Hold by converting it into defined entry conditions: breakout confirmation at $161.62 or pullback re-entry at $152-$155. The structural floor (1.37x FCF coverage, rising 200 SMA, 12+ year dividend growth streak) and exceptional Q2 inflection ($17B FCF) prevent underweight; forward EPS revision risk ($10.58 consensus implying 24% decline from Q2 peak annualized), ATR expansion (21% to $4.03), quintupled net debt, and completed buyback program prevent overweight. Risk/reward from $159.79 shows 6.4% upside to $170 vs 8.2% downside to $146—symmetry favors patience over adding. The 2.69% dividend yield materially reduces opportunity cost of holding.
| Position | Action |
|---|---|
| Maintain current position | Hold weight and harvest 2.69% dividend |
| Confirmed close above $161.62 with next-session hold above that level on >12M volume and MACD histogram positive | Tactical add 2-2.5% of portfolio (half of trader's 5% cap) |
| Breakout scenario fails first; price at $152-$155 with MACD turning positive and 10 EMA holding | Pullback add at $152-$155 |
| Sustained push to $170+ | Trim 10-15% of position |
| Close below $146 (50 SMA) on rising volume | Convert to review-and-reduce |
XOM is a mid-cycle turnaround with accelerating cash returns, trading at 15.1x forward earnings with a 2.69% growing yield, offering asymmetric upside through direct leverage to sustained crude disruption and its lowest-cost, highest-margin asset base.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $154.75 | bullish |
| 50 SMA | $146.74 | bullish |
| 200 SMA | $139.39 | bullish |
| MACD Line | +2.95 | bullish |
| MACD Signal Line | +2.87 | bullish |
| MACD Histogram | +0.08 | bullish |
| RSI (14) | 65.09 | bullish |
| Bollinger Upper Band | $161.62 | neutral |
| Bollinger Middle Band | $152.83 | neutral |
| Bollinger Lower Band | $144.04 | neutral |
| ATR (14) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price at $152-$155, MACD turning positive, 10 EMA holding — only if breakout scenario fails first
Then: Add at $152-$155 zone
Q2 2026 earnings represent a structural inflection, not a cyclical spike
EV: +9% to +14% · concedes: TTM PE of 26.9x is elevated — but reflects cyclical trough earnings, not forward earnings power; Q1 2026 weakness was real in terms of reported EPS — though explained by one-time tax charge; Bollinger upper band tag at $161.62 creates near-term resistance; Energy transition risk is a long-duration concern, not a near-term headwind; $81.63B buyback program is complete — next authorization pending; RSI at 65.09 is elevated, though not yet overbought
XOM's Q2 "inflection" is a cyclical peak disguised as structural earnings power—built on an abnormally low tax rate, a 2.7x operating cash flow swing, and a geopolitical premium that has a 46% probability of expiring within four months.
EV: -10.8% · concedes: Hess synergies from CVX are running ahead of plan (operational outperformance); The entire energy sector is repricing higher, so XOM is not uniquely exposed; Crude could remain elevated longer than expected if disruption persists; XOM's scale and liquidity provide some institutional support
→ vs conservative: The conservative analyst's 2.7x Q1-to-Q2 OCF swing cited as evidence of commodity cyclicality actually represents $23.6 billion in quarterly OCF—the highest in ExxonMobil's recent history—and Q2 produced nearly double the annualized base case for free cash flow, demolishing the cyclical risk framework
→ vs conservative: Net debt quintupling from ~$6 billion to $31.78 billion is framed as structural weakness but is actually a deliberate capital allocation choice; leverage ratio remains at 0.16x and the company is generating $17 billion in quarterly FCF while investing aggressively
→ vs conservative: The bear's probability-weighted minus 10.8% expected value is a model output that the market itself is rapidly invalidating—the tape is saying plus 15-20%
→ vs neutral: The neutral analyst acknowledges clean bullish technical stack (EMA alignment, MACD positive at +0.08, RSI at 65, volume confirming) and exceptional Q2 results but then says Hold because cases are 'genuinely balanced'—that is paralysis, not prudence
→ vs neutral: Waiting for pullback to $152-$155 (10 EMA and 20 SMA confluence) when trend is this strong and macro this supportive means risking getting run over; better to add at current levels with tighter mental stop
→ vs neutral: The trader's plan to add incrementally only on pullbacks capped at plus 5% portfolio incremental risk is too conservative given ATR at $4.03 and 0.17 beta create structurally compressed downside volatility
| $4.03 |
| neutral |
| VWMA (20) | $154.87 | bullish |
| Close | $159.79 | neutral |
| High | $160.36 | neutral |
| Low | $154.45 | neutral |
| Volume | 12.66M | neutral |
Support: 154.75 · 152.83 · 146.74 · 139.39 | Resistance: 161.62 · 170.08
XOM is in a strong, multi-month uptrend with bullish momentum confirmed by rising volume and a positive MACD cross. The stock is testing breakout resistance at the Bollinger Upper Band ($161.62); a decisive close above this level would be a strong continuation trigger toward the $170.08 prior swing high. Until then, the trend favors buying pullbacks to the $152-$155 zone with stops below the 10 EMA ($154.75). RSI at 65.09 remains below overbought threshold of 70, and ATR at $4.03 indicates elevated but manageable volatility requiring wider stop placement of 2× ATR (~$8).
Market Cap
$662.32B
Shares Outstanding
4.11B
Beta
0.17
52-Week High
$176.41
52-Week Low
$105.53
50-Day Avg
$146.48
200-Day Avg
$140.20
PE (TTM)
26.90x
Forward PE
15.10x
PEG Ratio
1.20
Price / Book
2.53x
EPS (TTM)
$5.94
Forward EPS
$10.58
Dividend Yield
2.69%
Book Value / Share
$63.08
EV / EBITDA (TTM)
~10.4x
Revenue (TTM)
$361.06B
Gross Profit (TTM)
$107.48B
EBITDA (TTM)
$67.94B
Net Income (TTM)
$32.76B
Operating Margin (TTM)
15.86%
Profit Margin (TTM)
9.07%
ROE (TTM)
12.58%
ROA (TTM)
5.52%
Revenue 2022
$398.7B
Revenue 2023
$334.7B
Revenue 2024
$339.2B
Revenue 2025
$323.9B
Net Income 2022
$55.7B
Net Income 2023
$36.0B
Net Income 2024
$33.7B
Net Income 2025
$28.8B
Diluted EPS 2022
$13.26
Diluted EPS 2023
$8.89
Diluted EPS 2024
$7.84
Diluted EPS 2025
$6.70
Q2 2026 Revenue
$114.5B
Q2 2026 Net Income
$14.53B
Q2 2026 EPS
$3.48
Q2 2026 EBITDA
$28.34B
Q1 2026 Revenue
$83.2B
Q1 2026 Net Income
$4.18B
Q1 2026 EPS
$1.00
Q2 2026 Operating CF
$23.56B
Q2 2026 Capex
$6.53B
Q2 2026 Free Cash Flow
$17.03B
Q2 2026 Total Assets
$464.48B
Q2 2026 Total Equity
$259.38B
Q2 2026 Total Debt
$42.37B
Q2 2026 Net Debt
$31.78B
Q2 2026 Cash & Equivalents
$10.59B
Q2 2026 Receivables
$60.56B
Total Assets 2022
$369.1B
Total Assets 2023
$376.3B
Total Assets 2024
$453.5B
Total Assets 2025
$449.0B
Total Equity 2022
$195.0B
Total Equity 2025
$259.4B
Total Debt 2022
$41.2B
Total Debt 2025
$43.5B
Net Debt 2022
$8.3B
Net Debt 2024
$14.7B
Net Debt 2025
$26.5B
Cash 2022
$29.6B
Cash 2025
$10.7B
Operating CF 2022
$76.8B
Operating CF 2023
$55.4B
Operating CF 2024
$55.0B
Operating CF 2025
$52.0B
Capex 2022
$18.4B
Capex 2025
$28.4B
Free Cash Flow 2022
$58.4B
Free Cash Flow 2025
$23.6B
Dividends 2022
$14.9B
Dividends 2025
$17.2B
Buybacks 2022
$15.2B
Buybacks 2025
$20.3B
Total Capital Return 2025
$37.5B
Annual Capex Run Rate
~$28B+
Annual Buybacks Run Rate
~$20.3B
Annual Dividends Run Rate
~$17.2B
Current Ratio Q1 2026
1.135
Real Debt/Equity
~0.16x
Effective Tax Rate Q2 2026
23.4%
Effective Tax Rate Q1 2026
35.8%
Q2 2026 Pretax Income
$19.42B
Q2 2026 Buybacks
$5.14B
Q2 2026 Dividends Paid
$4.30B
Q3 2025 EBITDA
$17.50B
Q4 2025 EBITDA
$15.91B
Q1 2026 EBITDA
$14.03B
Strengths
Concerns
ExxonMobil is a $662.32B integrated oil and gas supermajor trading on NYQ with an exceptionally low beta (0.17), making it behave like a utility. After three consecutive years of declining revenue ($398.7B→$323.9B) and earnings (EPS $13.26→$6.70) from 2022 peaks, Q2 2026 delivered a dramatic inflection with revenue +44% YoY to $114.5B, net income doubling to $14.53B, and FCF of $17.03B – the highest in recent history. The forward PE of 15.1x vs. TTM PE of 26.9x reflects market expectations for a ~78% earnings recovery, supported by Q2's strong print. The fortress balance sheet ($259.38B equity, real D/E ~0.16x) funds an aggressive capital return program of ~$37.5B annually (5.7% of market cap), combining dividends (2.69% yield) and buybacks (~$20.3B/year). The primary risk is commodity price reversal; if oil/gas holds current levels, the stock could re-rate toward $170-180.
Macro: FRED macro indicators unavailable due to missing API key; macro commentary grounded in news flow and Polymarket prediction market data. Dominant theme: Hormuz Strait reopening optimism has collapsed (Dec 31 normalcy only 46% on Polymarket), driving a 'risk-off but oil-on' tape. Brent crude rebounded to high $60s from ~$138 earlier in 2026. S&P fell -0.05% intraday, Nasdaq -0.15%, with T-note yields rising on the oil bid. Fed rate cuts 2026: 86% probability of zero cuts. US recession by end-2026: just 8%.